Predictive Value of Neutrophil/Lymphocyte Ratio (NLR) on Cardiovascular Events in Patients with COVID-19

References

• Roujian L, Xiang Z, Juan L, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet (London, England). 2020;1022:565–574.
   Google Scholar
• Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):1–8. doi:10.1038/s41586-020-2008-3
   Web of Science ®Google Scholar
• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 579:270–273.
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280. doi:10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Tay MZ, Poh CM, Rénia L, et al. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20(6):1–12. doi:10.1038/s41577-020-0311-8
   PubMed Web of Science ®Google Scholar
• Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020.
   Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:10223. doi:10.1016/S0140-6736(20)30183-5
   Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:10229. doi:10.1016/S0140-6736(20)30566-3
   Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus nfected Pneumonia in Wuhan, China. JAMA. 2020;323:1061. doi:10.1001/jama.2020.1585
   PubMed Web of Science ®Google Scholar
• Wu Z, Mcgoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: summary of a Report of 72 Cases From the Chinese Center for Disease Control and Prevention. J Am Med Assoc. 323.
   Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. J Integr Med. 2020.
   PubMedGoogle Scholar
• Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811. doi:10.1001/jamacardio.2020.1017
   PubMed Web of Science ®Google Scholar
• Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802. doi:10.1001/jamacardio.2020.0950
   PubMed Web of Science ®Google Scholar
• Shi S, Qin M, Cai Y, et al. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Eur Heart J. 2020;41(22):2070–2079. doi:10.1093/eurheartj/ehaa408
   PubMed Web of Science ®Google Scholar
• Riphagen S, Gomez X, Martínez CG, et al. Hyperinflammatory shock in children during COVID 19 pandemic. Lancet. 2020;395:1607–1608. doi:10.1016/S0140-6736(20)31094-1
   PubMed Web of Science ®Google Scholar
• Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 Pandemic. Elsevier Public Health Emergency Collection. 75(18).
   Google Scholar
• Madjid M, Safavi-Naeini P, Solomon SD, et al. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5(7). doi:10.1001/jamacardio.2020.1286.
   PubMed Web of Science ®Google Scholar
• Fulchand S. Covid-19 and cardiovascular disease. BMJ (Online). 2020;369:m1997.
   PubMedGoogle Scholar
• Wilhelmsen L. Leukocytes and coronary heart disease. Aust N Z J Med. 1980;10(2):135–138. doi:10.1111/j.1445-5994.1980.tb03700.x
   PubMedGoogle Scholar
• Venkatraghavan L, Tan TP, Mehta J. et al. Neutrophil Lymphocyte Ratio as a predictor of systemic inflammation - A cross-sectional study in a pre-admission setting. F1000 Res;2015. 4. doi:10.12688/f1000research.6474.1
   PubMedGoogle Scholar
• Wang X, Zhang G, Jiang X, Zhu H, Lu Z, Xu L. Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies. Atherosclerosis. 2014;234(1):206–213. doi:10.1016/j.atherosclerosis.2014.03.003
   PubMed Web of Science ®Google Scholar
• Giuseppe DL, Monica V. Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: a systematic review and meta-analysis of the literature. Int J Cardiol. 2018;266:31–37. doi:10.1016/j.ijcard.2018.02.116
   PubMed Web of Science ®Google Scholar
• Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809–815. doi:10.1016/S0140-6736(20)30360-3
   PubMed Web of Science ®Google Scholar
• Stevens PE. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825. doi:10.7326/0003-4819-158-11-201306040-00007
   PubMed Web of Science ®Google Scholar
• Li SS, Cheng CW, Fu CL, et al. Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study. Circulation. 2003;108(15).
   Web of Science ®Google Scholar
• Peiris J, Chu CM, Cheng V. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361(9371):1767–1772. doi:10.1016/S0140-6736(03)13412-5
   PubMed Web of Science ®Google Scholar
• Zheng YY, Ma YT, Zhang JY, et al. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):1–2. doi:10.1038/s41569-020-0360-5
   PubMed Web of Science ®Google Scholar
• Grasselli G, Zangrillo A, Zanella A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574. doi:10.1001/jama.2020.5394
   PubMed Web of Science ®Google Scholar
• Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of COVID-19 in New York City. New Engl J Med. 2020;382(24):2372–2374. doi:10.1056/NEJMc2010419
   PubMed Web of Science ®Google Scholar
• Jiang F, Deng L, Zhang L, et al. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19). J Gen Intern Med. 2020;35(5):1545–1549. doi:10.1007/s11606-020-05762-w.
   Google Scholar
• Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020. doi:10.1001/jama.2020.4683
   PubMed Web of Science ®Google Scholar
• Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of coronavirus in COVID‐19 cardiogenic shock. Eur J Heart Fail. 2020;22(5):911–915. doi:10.1002/ejhf.1828
   PubMed Web of Science ®Google Scholar
• Wichmann D, Sperhake JP, Lütgehetmann M, et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: a Prospective Cohort Study. Ann Intern Med. 2020;173(4).
   Web of Science ®Google Scholar
• Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422. doi:10.1016/S2213-2600(20)30076-X
   PubMed Web of Science ®Google Scholar
• Ahsen A, Ulu MS, Yuksel S, et al. As a new inflammatory marker for familial mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation. 2013;36(6):1357–1362. doi:10.1007/s10753-013-9675-2
   PubMed Web of Science ®Google Scholar
• Günay E, Ulal SS, Akar O, et al. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. Inflammation. 2014;37(2):374–380. doi:10.1007/s10753-013-9749-1
   PubMed Web of Science ®Google Scholar
• Eastin C, Eastin T. Characteristics and Outcomes of 21 Critically Ill Patients with COVID-19 in Washington State. J Emergency Med. 2020;58(4):710.
   Google Scholar
• Schaller T, Hirschbühl K, Burkhardt K, et al. Postmortem Examination of Patients with COVID-19. JAMA. 2020;323(24).
   PubMed Web of Science ®Google Scholar
• Jiang F, Yang J, Zhang Y, et al. Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets. Nat Rev Cardiol. 2014;11(7):413–426. doi:10.1038/nrcardio.2014.59
   PubMed Web of Science ®Google Scholar
• Oudit GY, Kassiri Z, Jiang C, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2010;39(7):618–625. doi:10.1111/j.1365-2362.2009.02153.x
   Web of Science ®Google Scholar
• Kwong JC, Schwartz KL, Campitelli MA, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. New Engl J Med. 2018;378(4):345–353. doi:10.1056/NEJMoa1702090
   PubMed Web of Science ®Google Scholar